gouty arthritis
Conditions
Interventions
experimental group :jinjuqubifang
control group:Fesibut tablets
Sponsors
Affiliated Hospital of Gansu University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1) Voluntary enrollment with signed informed consent; 2) Compliance with the 2015 American College of Rheumatology/European League Against Rheumatism Gout Classification Criteria; 3) Age 18-60 years (gender unrestricted), with self-care capacity; 4) Patients demonstrating treatment adherence, completion of scheduled regimens, and cooperation with clinical observers for follow-up monitoring; 5) Participants fully comprehend the study's objectives, their condition specifics, trial medication characteristics, treatment protocols, and potential risks before signing the informed consent form.
Exclusion criteria
Exclusion criteria: 1) Patients with comorbidities causing concurrent joint pain; 2) Those with severe primary diseases (hematopoietic system disorders, liver/kidney diseases, pulmonary conditions) or psychiatric disorders; 3) Pregnant or breastfeeding women; 4) Participants currently enrolled in other drug-related clinical trials or research programs; 5) Individuals exhibiting mental, cognitive, or consciousness abnormalities that impair treatment compliance; 6) Suspected secondary HUA cases (e.g., those undergoing tumor radiotherapy/chemotherapy, anti-tuberculosis medication use); 7) Subjects deemed unsuitable by investigators due to frequent job relocations, unstable living environments, or other factors likely causing follow-up discontinuation; 8) Patients with severe hypertension or cardiovascular/cerebrovascular diseases; 9) Those allergic to traditional Chinese medicine or febuxostat.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Uric acid;erythrocyte sedimentation rate (ESR) ;C reactive protein ; | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual Analogue Scale for Pain;Traditional Chinese Medicine Syndrome Rating; | — |
Countries
the People's Republic of China (PRC)
Contacts
Public ContactXie Xingwen
Affiliated Hospital of Gansu University of Chinese Medicine
Outcome results
None listed